Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
about
Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recoveryA connecting hinge represses the activity of endothelial nitric oxide synthase.Nitric oxide synthase gene therapy: progress and prospects.Extracorporeal shock wave therapy for ischemic cardiovascular disorders.Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.
P2860
Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effective treatment of vascula ...... al nitric oxide synthase gene.
@ast
Effective treatment of vascula ...... al nitric oxide synthase gene.
@en
type
label
Effective treatment of vascula ...... al nitric oxide synthase gene.
@ast
Effective treatment of vascula ...... al nitric oxide synthase gene.
@en
prefLabel
Effective treatment of vascula ...... al nitric oxide synthase gene.
@ast
Effective treatment of vascula ...... al nitric oxide synthase gene.
@en
P2093
P2860
P356
P1433
P1476
Effective treatment of vascula ...... al nitric oxide synthase gene.
@en
P2093
Halks-Miller M
Kretschmer P
P2860
P2888
P304
P356
10.1038/SJ.GT.3302781
P577
2006-04-27T00:00:00Z